glp-1 options for type 2 diabetes and obesity 2025 New Guidelines in FDA-approved GLP-1 medications like Zepbound®

465 Impaired GLP-1 secretion or reduced GLP-1R expression may result in aberrantly heightened sympathetic excitation

Never share injection pens or devices with others, even if the needle has been changed, as this poses serious infection risks

Ludvik B, Giorgino F, Jdar E, et al

1.2 Safety considerations and the limits of the GLP-1 analogy The success of GLP-1 receptor agonists should not obscure legitimate safety considerations associated with chronic peptide therapy

Medvi did not respond to WIRED's requests for comment

For example, insulin resistance is emerging as a key indicator of Alzheimers disease and Parkinsons disease